NASDAQ:MDWD

Mediwound Stock Insider Trading

Healthcare > Biotechnology

Buy MDWD

*Your capital is at risk

$14.12

+0.0200 (+0.142%)

At Close: Jul 31, 2026

MediWound Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 760.08K and sold 0 MDWD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	760.08K shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 26, 2025 Buy	Stock Option (right to buy ordinary shares)	Driver Vickie Rae Director	Director	7 542 Value: $96.0K
Feb 26, 2025 Buy	Stock Option (right to buy ordinary shares)	Fox David Morton Director	Director	7 542 Value: $96.0K
Feb 26, 2025 Buy	Stock Option (right to buy ordinary shares)	Wills Stephen T Director	Director	7 542 Value: $96.0K
Feb 26, 2025 Buy	Stock Option (right to buy ordinary shares)	Rubinstein Samuel Director	Director	7 542 Value: $96.0K
Aug 15, 2024 Buy	Stock Option (right to buy ordinary shares)	Rubinstein Samuel Director	Director	7 200 Value: $69.4K
May 31, 2024 Buy	Stock Option (right to buy ordinary shares)	Driver Vickie Rae Director	Director	5 900 Value: $70.1K
May 31, 2024 Buy	Stock Option (right to buy ordinary shares)	Fox David Morton Director	Director	5 900 Value: $70.1K
May 31, 2024 Buy	Stock Option (right to buy ordinary shares)	Wills Stephen T Director	Director	5 900 Value: $70.1K
Apr 23, 2024 Buy	Stock Option (right to buy ordinary shares)	Klinger Ety Chief Medical Officer	Officer	5 491 Value: $67.3K
Apr 23, 2024 Buy	Stock Option (right to buy ordinary shares)	Ben Yaakov Aya Vp Clinical & Reg. Affairs	Officer	571 Value: $7K
Apr 23, 2024 Buy	Stock Option (right to buy ordinary shares)	Meyer Yaron EVP, GC & Corp. Secretary	Officer	4 919 Value: $60.3K
May 16, 2023 Buy	Stock Option (right to buy ordinary shares)	Driver Vickie Rae Director	Director	5 357 Value: $77.2K
May 16, 2023 Buy	Stock Option (right to buy ordinary shares)	Fox David Morton Director	Director	5 357 Value: $77.2K
May 16, 2023 Buy	Stock Option (right to buy ordinary shares)	Wills Stephen T Director	Director	10 714 Value: $154.5K
Dec 31, 2022 Buy	Stock Option (right to buy ordinary shares)	Klinger Ety Chief Medical Officer	Officer	3 571 Value: $128.7K
Dec 31, 2022 Buy	Stock Option (right to buy ordinary shares)	Ben Yaakov Aya Vp Clinical & Reg. Affairs	Officer	1 571 Value: $56.6K
Dec 31, 2022 Buy	Stock Option (right to buy ordinary shares)	Meyer Yaron EVP, GC & Corp. Secretary	Officer	2 857 Value: $103.0K
Nov 28, 2022 Buy	Series A Warrants	Fox David Morton Director	Director	6 534 Value: $88.0K
Jun 15, 2022 Buy	Stock Option (right to buy ordinary shares)	Driver Vickie Rae Director	Director	1 607 Value: $60.3K
Jun 15, 2022 Buy	Stock Option (right to buy ordinary shares)	Fox David Morton Director	Director	1 607 Value: $60.3K
Jun 15, 2022 Buy	Stock Option (right to buy ordinary shares)	Wills Stephen T Director	Director	3 214 Value: $120.6K
Jun 29, 2021 Buy	Stock Option (right to buy ordinary shares)	Driver Vickie Rae Director	Director	14 285 Value: $175.0K
Jun 29, 2021 Buy	Stock Option (right to buy ordinary shares)	Fox David Morton Director	Director	14 285 Value: $175.0K
Jun 29, 2021 Buy	Stock Option (right to buy ordinary shares)	Wills Stephen T Director	Director	14 285 Value: $175.0K
Mar 24, 2020 Buy	Stock Option (right to buy ordinary shares)	Wills Stephen T Director	Director	2 857 Value: $98.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MEDIWOUND LTD.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for ...

Read Full Profile Here